69 related articles for article (PubMed ID: 16110320)
1. Apaf-1 expression in malignant melanoma.
Soengas MS; Gerald WL; Cordon-Cardo C; Lazebnik Y; Lowe SW
Cell Death Differ; 2006 Feb; 13(2):352-3. PubMed ID: 16110320
[No Abstract] [Full Text] [Related]
2. APAF-1 signaling in human melanoma.
Anichini A; Mortarini R; Sensi M; Zanon M
Cancer Lett; 2006 Jul; 238(2):168-79. PubMed ID: 16095810
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase activity regulates apaf-1 and caspase 3 expression in the developing mouse retina.
Wallace DM; Donovan M; Cotter TG
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2765-72. PubMed ID: 16799012
[TBL] [Abstract][Full Text] [Related]
4. Analysis of APAF-1 expression in human cutaneous melanoma progression.
Baldi A; Santini D; Russo P; Catricalà C; Amantea A; Picardo M; Tatangelo F; Botti G; Dragonetti E; Murace R; Tonini G; Natali PG; Baldi F; Paggi MG
Exp Dermatol; 2004 Feb; 13(2):93-7. PubMed ID: 15009102
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the apoptosis effector Apaf-1 in malignant melanoma.
Soengas MS; Capodieci P; Polsky D; Mora J; Esteller M; Opitz-Araya X; McCombie R; Herman JG; Gerald WL; Lazebnik YA; Cordón-Cardó C; Lowe SW
Nature; 2001 Jan; 409(6817):207-11. PubMed ID: 11196646
[TBL] [Abstract][Full Text] [Related]
6. Is Apaf-1 expression frequently abrogated in melanoma?
Allen JD; Zhang XD; Scott CL; Boyle GM; Hersey P; Strasser A
Cell Death Differ; 2005 Jun; 12(6):680-1. PubMed ID: 15832174
[No Abstract] [Full Text] [Related]
7. Expression and function of the apoptosis effector Apaf-1 in melanoma.
Peltenburg LT; de Bruin EC; Meersma D; Smit NP; Schrier PI; Medema JP
Cell Death Differ; 2005 Jun; 12(6):678-9. PubMed ID: 15832175
[No Abstract] [Full Text] [Related]
8. Role of Apaf-1, a key regulator of apoptosis, in melanoma progression and chemoresistance.
Campioni M; Santini D; Tonini G; Murace R; Dragonetti E; Spugnini EP; Baldi A
Exp Dermatol; 2005 Nov; 14(11):811-8. PubMed ID: 16232302
[TBL] [Abstract][Full Text] [Related]
9. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
[TBL] [Abstract][Full Text] [Related]
10. Mutant p53 melanoma cell lines respond differently to CP-31398-induced apoptosis.
Ho CK; Li G
Br J Dermatol; 2005 Nov; 153(5):900-10. PubMed ID: 16225598
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of Apaf-1 and caspase-3 by RNA interference in human glioma cells: consequences for erucylphosphocholine-induced apoptosis.
Kugler W; Buchholz F; Köhler F; Eibl H; Lakomek M; Erdlenbruch B
Apoptosis; 2005 Oct; 10(5):1163-74. PubMed ID: 16151649
[TBL] [Abstract][Full Text] [Related]
12. [Living and letting die--new mechanisms of apoptosis resistance in melanoma cells]].
Hautarzt; 2001 Apr; 52(4):386-7. PubMed ID: 11382133
[No Abstract] [Full Text] [Related]
13. Decreased expression of Apaf-1 with progression of melanoma.
Mustika R; Budiyanto A; Nishigori C; Ichihashi M; Ueda M
Pigment Cell Res; 2005 Feb; 18(1):59-62. PubMed ID: 15649154
[TBL] [Abstract][Full Text] [Related]
14. Variants in Apaf-1 segregating with major depression promote apoptosome function.
Harlan J; Chen Y; Gubbins E; Mueller R; Roch JM; Walter K; Lake M; Olsen T; Metzger P; Dorwin S; Ladror U; Egan DA; Severin J; Johnson RW; Holzman TF; Voelp K; Davenport C; Beck A; Potter J; Gopalakrishnan M; Hahn A; Spear BB; Halbert DN; Sullivan JP; Abkevich V; Neff CD; Skolnick MH; Shattuck D; Katz DA
Mol Psychiatry; 2006 Jan; 11(1):76-85. PubMed ID: 16231040
[TBL] [Abstract][Full Text] [Related]
15. PAX4 has the potential to function as a tumor suppressor in human melanoma.
Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T
Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370
[TBL] [Abstract][Full Text] [Related]
16. Cancer. Death and methylation.
Jones PA
Nature; 2001 Jan; 409(6817):141, 143-4. PubMed ID: 11196623
[No Abstract] [Full Text] [Related]
17. Expression of Hugl-1 is strongly reduced in malignant melanoma.
Kuphal S; Wallner S; Schimanski CC; Bataille F; Hofer P; Strand S; Strand D; Bosserhoff AK
Oncogene; 2006 Jan; 25(1):103-10. PubMed ID: 16170365
[TBL] [Abstract][Full Text] [Related]
18. Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma.
Rothhammer T; Bosserhoff AK
Melanoma Res; 2006 Aug; 16(4):309-16. PubMed ID: 16845326
[TBL] [Abstract][Full Text] [Related]
19. Detection of mitochondria-mediated apoptosis signaling molecules in ameloblastomas.
Kumamoto H; Ooya K
J Oral Pathol Med; 2005 Oct; 34(9):565-72. PubMed ID: 16138896
[TBL] [Abstract][Full Text] [Related]
20. Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches.
Eberle J; Kurbanov BM; Hossini AM; Trefzer U; Fecker LF
Drug Resist Updat; 2007 Dec; 10(6):218-34. PubMed ID: 18054518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
